Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eaton Corporation plc (ETN) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Eaton Corporation plcTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Eaton Corporation plc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $429.65 (market cap $164.88B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Eaton Corporation plc is far larger — about 27.3× Iovance Biotherapeutics Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.04% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

ETNIOVA
Market Cap
$164.88B$6.04B
Volume
2,535,08614,805,993
Sector
IndustrialsHealth
52-Week High
$459.96$14.82
52-Week Low
$315.82$1.81
Typical Hold Time
31 Days0 Days
Enterprise Value
$185.51B$5.97B
Dividend Yield
1.04%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eaton Corporation plc

Eaton Corporation (ETN) trades at $429.65, down 0.39% on the day, with technical indicators showing a bearish bias despite recent earnings beats. The company maintains strong fundamentals with 12.75% net income margin and 19.71% ROE, supported by strategic acquisitions in data center and aerospace markets. Analyst consensus remains strongly bullish with a $502.38 price target, representing 17% upside potential from current levels.

ETN's outlook remains positive driven by data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.23) and bearish technical signals warrant caution. The stock faces execution risks from recent acquisitions and competitive pressure in the electrical equipment sector, but strong institutional support and consistent earnings performance support the bullish analyst stance.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ETN
100% Buy0% Sell
Avg holding period · 31 Days
IOVA
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →